Supercharged donor cells aim to stop leukemia return after transplant
NCT ID NCT07702578
First seen Jul 14, 2026 · Last updated Jul 23, 2026 · Updated 5 times
Summary
This study tests a new approach to prevent leukemia from coming back after a stem cell transplant. It uses donor T cells that have been engineered to recognize and attack a specific target (HA-2) on leukemia cells. The trial enrolls adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) who are receiving a stem cell transplant from a partially matched donor. Half receive the engineered cells plus standard care, and half receive standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TSC-101, a T-cell receptor engineered donor T cell therapy targeting HA-2
- What this could lead to
- If successful, TSC-101 could reduce the risk of leukemia relapse after stem cell transplant, potentially leading to higher cure rates for AML and MDS.
- What could go wrong
- This is an early-phase trial, so the benefits are not proven. There may be risks like graft-versus-host disease or other immune reactions. The therapy only works for patients with a specific genetic marker (HLA-A*02:01).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner Health - MD Anderson Cancer Center
NOT_YET_RECRUITINGGilbert, Arizona, 85234, United States
Contact
-
Baylor University Medical Center
RECRUITINGDallas, Texas, 75246, United States
Contact
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
-
Columbia University - Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact
-
Dana-Farber Cancer Institute - Hematology/Oncology
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Froedtert & Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
-
Honor Health Cancer Transplant Institute
NOT_YET_RECRUITINGScottsdale, Arizona, 85258, United States
Contact
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
Contact
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
-
Memorial Cancer Institute
RECRUITINGHollywood, Florida, 33021, United States
Contact
-
Moffitt Cancer Institute
RECRUITINGTampa, Florida, 33612, United States
Contact
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
Contact
-
Northside Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
Contact
-
SCRI - Colorado Blood Cancer Institute
RECRUITINGDenver, Colorado, 80218, United States
Contact
-
Sarah Cannon Research Institute - TriStar Bone Marrow Transplant (BMT)
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
St. David's South Austin Medical Center
RECRUITINGAustin, Texas, 76704, United States
Contact
-
Stanford - School of Medicine
NOT_YET_RECRUITINGStanford, California, 94305, United States
Contact
-
The University of Kansas Cancer Center
NOT_YET_RECRUITINGKansas City, Kansas, 66160, United States
Contact
-
The University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact
-
The University of Texas - MD Anderson Cancer Center
RECRUITINGHouston, Texas, 76704, United States
Contact
-
University of Chicago
NOT_YET_RECRUITINGChicago, Illinois, 60607, United States
Contact
-
University of Colorado - Anschutz Cancer Center
RECRUITINGAurora, Colorado, 80045, United States
Contact
-
Yale
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressurized oxygen boost cord blood transplants?
- Personalized leukemia vaccine aims to outsmart relapse
- Worldwide data pool could pave the way for mitochondrial disease trials
- Artificial intelligence could help prevent transplant complications by personalizing drug dosing
- New drug aims to wake up immune system against Hard-to-Treat leukemia
- Experimental CAR-T therapy takes on tough leukemia